Alexander Valvezan's Avatar

Alexander Valvezan

@alexandervalvezan.bsky.social

Assistant Professor at Rutgers Robert Wood Johnson Medical School. Studying cancer signaling and metabolism, with interest in cell cycle phase-specific effects

74 Followers  |  137 Following  |  4 Posts  |  Joined: 04.06.2025
Posts Following

Posts by Alexander Valvezan (@alexandervalvezan.bsky.social)

Preview
Structural basis for mTORC1 activation on the lysosomal membrane - Nature Cryo-electron microscopy was used to study human mechanistic target of rapamycin complex 1 (mTORC1) activation on lysosomal membranes, showing progressive recruitment by RAG–Ragulator, RHEB and R...

Finally in @nature.com πŸŽ‰
We uncovered step-wise mTORC1 activation on membrane: RAG–Ragulator recruits, RHEB pushes closer, and direct membrane contacts by RAPTOR + mTOR trigger full kinase activity.πŸ‘‰ The membrane is not just a platform β€” it’s part of the mechanism.
www.nature.com/articles/s41...

17.09.2025 21:35 β€” πŸ‘ 35    πŸ” 14    πŸ’¬ 5    πŸ“Œ 2

Congrats on this awesome work!

18.09.2025 21:44 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0

Congrats on this awesome work!

18.09.2025 21:44 β€” πŸ‘ 0    πŸ” 1    πŸ’¬ 0    πŸ“Œ 0
Rutgers University Employment Opportunities

πŸ“’Interested in #CancerMetabolism and #leukemia using mouse models in vivo? Come join us!! We're looking for a #postdoc to help us drive one of our multiple currently funded projects! Friends & colleagues, please RT!
πŸ‘‡πŸ‘‡πŸ‘‡
jobs.rutgers.edu/postings/260...

18.09.2025 02:10 β€” πŸ‘ 3    πŸ” 8    πŸ’¬ 0    πŸ“Œ 0
Preview
Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry - Nature APC/C activity is transiently inhibited to generate a pulse of glycolysis that is required for mammalian cell cycle entry.

Very cool paper.

Transient APC/C inactivation by mTOR boosts glycolysis during cell cycle entry

www.nature.com/articles/s41...

12.08.2025 17:32 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Preview
I Was Just About To When My Grant Was Cut. We ask researchers to send us their stories of what they were working on when their research grant was cut. Today, we share the stories of Tashara and Brendan.

Just two of thousands of such stories. substack.com/home/post/p-...

29.07.2025 14:15 β€” πŸ‘ 5    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0
Preview
Conservation and divergence of metabolic phenotypes between patient tumours and matched xenografts - Nature Metabolism Rao and Cai et al. perform a detailed metabolic comparison between primary tumours from patients and their matching xenografts, which identify conserved as well as divergent metabolic patterns.

1/Patient-derived xenografts (PDXs) are used in preclinical testing of cancer therapies, including metabolic therapies. We determined which metabolic properties are retained, and which are lost, when melanomas from patients are implanted and passaged as PDXs in mice.
www.nature.com/articles/s42...

29.07.2025 14:56 β€” πŸ‘ 55    πŸ” 19    πŸ’¬ 4    πŸ“Œ 2

Inspired predominantly by insightful cryo-EM structures from Yanhui Xu’s lab and @drellisdon.bsky.social on the TSC protein complex, which we have been focused on the regulation of upstream of mTORC1 for 23 years and counting. Enjoy!

09.07.2025 00:38 β€” πŸ‘ 14    πŸ” 7    πŸ’¬ 1    πŸ“Œ 0

Congrats to Yann Cormerais and the entire lab for this publication on a new mouse model that disconnects the primary signal from PI3K to mTORC1, involving Akt-mediated phosphorylation of TSC2, which I discovered as a postdoc in Lew Cantley's lab 23 years ago. authors.elsevier.com/a/1lDFh5Sx5g...

05.06.2025 15:33 β€” πŸ‘ 17    πŸ” 6    πŸ’¬ 4    πŸ“Œ 0

Congratulations Brendan, Yann and everyone else involved!

10.06.2025 22:34 β€” πŸ‘ 2    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0
Post image

Happy to share the copy-edited version of our story uncovering an ACLY-MYC feedforward loop in T-ALL! @bloodneoplasia.bsky.social @rutgerscancer.bsky.social @dasilva-diz.bsky.social

doi.org/10.1016/j.bn...

26.03.2025 16:50 β€” πŸ‘ 4    πŸ” 4    πŸ’¬ 0    πŸ“Œ 0

Hello BlueSky, finally joined and looking to reconnect with everyone here!

04.06.2025 15:39 β€” πŸ‘ 3    πŸ” 0    πŸ’¬ 0    πŸ“Œ 0